Commonwealth Equity Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134,037	Closed	-$118K	–	3907
2022 Q4	$118K	Sell	134,037 -11,192	-8%	-$14.8K	﹤0.01%	3382
2022 Q3	$228K	Sell	145,229 -20,488	-12%	-$46.5K	﹤0.01%	3062
2022 Q2	$333K	Buy	165,717 +9,415	+6%	+$16.3K	﹤0.01%	2744
2022 Q1	$364K	Buy	156,302 +72,340	+86%	+$226K	﹤0.01%	2797
2021 Q4	$390K	Sell	83,962 -5,300	-6%	-$32.9K	﹤0.01%	2739
2021 Q3	$681K	Buy	89,262 +3,380	+4%	+$28.7K	﹤0.01%	2237
2021 Q2	$832K	Buy	85,882 +11,445	+15%	+$91.1K	﹤0.01%	2057
2021 Q1	$615K	Sell	74,437 -11,394	-13%	-$120K	﹤0.01%	2156
2020 Q4	$585K	Buy	85,831 +20,478	+31%	+$164K	﹤0.01%	2038
2020 Q3	$728K	Sell	65,353 -34,413	-34%	-$315K	﹤0.01%	1694
2020 Q2	$626K	Buy	99,766 +76,246	+324%	+$292K	﹤0.01%	1728
2020 Q1	$43K	Buy	23,520 +13,100	+126%	+$37.7K	﹤0.01%	2698
2019 Q4	$35K	Sell	10,420 -6,526	-39%	-$15.6K	﹤0.01%	2830
2019 Q3	$36K	Buy	16,946 +6,763	+66%	+$15.8K	﹤0.01%	2764
2019 Q2	$27K	Hold	10,183	–	–	﹤0.01%	2728
2019 Q1	$48K	Sell	10,183 -29,414	-74%	-$77.2K	﹤0.01%	2665
2018 Q4	$95K	Buy	39,597 +14,916	+60%	+$48.7K	﹤0.01%	2499
2018 Q3	$108K	Sell	24,681 -112,556	-82%	-$624K	﹤0.01%	2630
2018 Q2	$988K	Buy	137,237 +9,146	+7%	+$62.2K	0.01%	1289
2018 Q1	$659K	Buy	+128,091	New	+$911K	﹤0.01%	1511